Loading…

Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet

Sodium diclofenac (SD) release from dosage forms has been studied under different conditions. However, no dissolution method that is discriminatory enough to reflect slight changes in formulation or manufacturing process, and which could be effectively correlated with the biological properties of th...

Full description

Saved in:
Bibliographic Details
Published in:International journal of pharmaceutics 2010-02, Vol.386 (1), p.201-207
Main Authors: Mourão, Samanta C., da Silva, Cristiane, Bresolin, Tania M.B., Serra, Cristina H.R., Porta, Valentina
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c394t-902e2ef561a4d06667aa32df8760a0e60422350fe5b086c9184a64e91dd6762c3
cites
container_end_page 207
container_issue 1
container_start_page 201
container_title International journal of pharmaceutics
container_volume 386
creator Mourão, Samanta C.
da Silva, Cristiane
Bresolin, Tania M.B.
Serra, Cristina H.R.
Porta, Valentina
description Sodium diclofenac (SD) release from dosage forms has been studied under different conditions. However, no dissolution method that is discriminatory enough to reflect slight changes in formulation or manufacturing process, and which could be effectively correlated with the biological properties of the dosage form, has been reported. This study sought to develop three different formulae of SD-containing matrix tablets and to determine the effect of agitation speed in its dissolution profiles. F1, F2 and F3 formulations were developed using hypromellose (10, 20 and 30%, respectively for F1, F2 and F3) and other conventional excipients. Dissolution tests were carried out in phosphate buffer pH 6.8 at 37 °C using apparatus II at 50, 75 or 100 rpm. Dissolution efficiency (DE), T 50 and T 90 were determined and plotted as functions of the variables agitation speed and hypromellose concentration. Regarding DE, F2 showed more sensitivity to variations in agitation speed than F1 and F3. Increasing hypromellose concentration reduced DE values, independent of agitation speed. Analysis of T 50 and T 90 suggests that F1 is less sensitive to variations in agitation speed than F2 and F3. Most discriminatory dissolution conditions were observed at 50 rpm. Results suggest that the comparison of dissolution performance of SD matrix tablets should take into account polymer concentration and agitation conditions.
doi_str_mv 10.1016/j.ijpharm.2009.11.022
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733863728</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517309008242</els_id><sourcerecordid>733863728</sourcerecordid><originalsourceid>FETCH-LOGICAL-c394t-902e2ef561a4d06667aa32df8760a0e60422350fe5b086c9184a64e91dd6762c3</originalsourceid><addsrcrecordid>eNqFkE1v1TAQRS0Eoo_CTwBlg7pKGH_ETlYIlVKQKiFVZW3NsyfUT0n8sB1E_z2pXgTLrmZz7p2rw9hbDg0Hrj8cmnA43mOaGgHQN5w3IMQztuOdkbVURj9nO5Cmq1tu5Bl7lfMBALTg8iU7432veK_Ujt1-DjnHcSkhztURE05UKOVqiKnK0YdlqnxwYxxoRle7OBcMc5h_VvcPxxQnGseYqZqwpPCnKrgfqbxmLwYcM73Z7jn78eXq7vJrffP9-tvlp5vayV6VugdBgoZWc1QetNYGUQo_dEYDAmlQQsgWBmr30GnX806hVtRz77XRwslzdnHqXYf8WigXO4Xs1kU4U1yyNVJ2WhrRrWR7Il2KOSca7DGFCdOD5WAfbdqD3WzaR5uWc7vaXHPvtg_LfiL_P7XpW4H3G4DZ4TgknF3I_zghlGkFh5X7eOJo9fE7ULLZBZod-ZDIFetjeGLKX5L-lmc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733863728</pqid></control><display><type>article</type><title>Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet</title><source>ScienceDirect Journals</source><creator>Mourão, Samanta C. ; da Silva, Cristiane ; Bresolin, Tania M.B. ; Serra, Cristina H.R. ; Porta, Valentina</creator><creatorcontrib>Mourão, Samanta C. ; da Silva, Cristiane ; Bresolin, Tania M.B. ; Serra, Cristina H.R. ; Porta, Valentina</creatorcontrib><description>Sodium diclofenac (SD) release from dosage forms has been studied under different conditions. However, no dissolution method that is discriminatory enough to reflect slight changes in formulation or manufacturing process, and which could be effectively correlated with the biological properties of the dosage form, has been reported. This study sought to develop three different formulae of SD-containing matrix tablets and to determine the effect of agitation speed in its dissolution profiles. F1, F2 and F3 formulations were developed using hypromellose (10, 20 and 30%, respectively for F1, F2 and F3) and other conventional excipients. Dissolution tests were carried out in phosphate buffer pH 6.8 at 37 °C using apparatus II at 50, 75 or 100 rpm. Dissolution efficiency (DE), T 50 and T 90 were determined and plotted as functions of the variables agitation speed and hypromellose concentration. Regarding DE, F2 showed more sensitivity to variations in agitation speed than F1 and F3. Increasing hypromellose concentration reduced DE values, independent of agitation speed. Analysis of T 50 and T 90 suggests that F1 is less sensitive to variations in agitation speed than F2 and F3. Most discriminatory dissolution conditions were observed at 50 rpm. Results suggest that the comparison of dissolution performance of SD matrix tablets should take into account polymer concentration and agitation conditions.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2009.11.022</identifier><identifier>PMID: 19941944</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Anti-Inflammatory Agents, Non-Steroidal - chemistry ; Biological and medical sciences ; Buffers ; Chemistry, Pharmaceutical ; Delayed-Action Preparations ; Diclofenac - chemistry ; Dissolution assay ; Dissolution kinetics ; Drug Carriers ; General pharmacology ; Hardness ; Hydrogen-Ion Concentration ; Hypromellose ; Hypromellose Derivatives ; Kinetics ; Medical sciences ; Methylcellulose - analogs &amp; derivatives ; Methylcellulose - chemistry ; Models, Chemical ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Sodium diclofenac ; Solubility ; Tablets ; Technology, Pharmaceutical - methods ; Temperature</subject><ispartof>International journal of pharmaceutics, 2010-02, Vol.386 (1), p.201-207</ispartof><rights>2009</rights><rights>2015 INIST-CNRS</rights><rights>Copyright 2009. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c394t-902e2ef561a4d06667aa32df8760a0e60422350fe5b086c9184a64e91dd6762c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22475210$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19941944$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mourão, Samanta C.</creatorcontrib><creatorcontrib>da Silva, Cristiane</creatorcontrib><creatorcontrib>Bresolin, Tania M.B.</creatorcontrib><creatorcontrib>Serra, Cristina H.R.</creatorcontrib><creatorcontrib>Porta, Valentina</creatorcontrib><title>Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>Sodium diclofenac (SD) release from dosage forms has been studied under different conditions. However, no dissolution method that is discriminatory enough to reflect slight changes in formulation or manufacturing process, and which could be effectively correlated with the biological properties of the dosage form, has been reported. This study sought to develop three different formulae of SD-containing matrix tablets and to determine the effect of agitation speed in its dissolution profiles. F1, F2 and F3 formulations were developed using hypromellose (10, 20 and 30%, respectively for F1, F2 and F3) and other conventional excipients. Dissolution tests were carried out in phosphate buffer pH 6.8 at 37 °C using apparatus II at 50, 75 or 100 rpm. Dissolution efficiency (DE), T 50 and T 90 were determined and plotted as functions of the variables agitation speed and hypromellose concentration. Regarding DE, F2 showed more sensitivity to variations in agitation speed than F1 and F3. Increasing hypromellose concentration reduced DE values, independent of agitation speed. Analysis of T 50 and T 90 suggests that F1 is less sensitive to variations in agitation speed than F2 and F3. Most discriminatory dissolution conditions were observed at 50 rpm. Results suggest that the comparison of dissolution performance of SD matrix tablets should take into account polymer concentration and agitation conditions.</description><subject>Anti-Inflammatory Agents, Non-Steroidal - chemistry</subject><subject>Biological and medical sciences</subject><subject>Buffers</subject><subject>Chemistry, Pharmaceutical</subject><subject>Delayed-Action Preparations</subject><subject>Diclofenac - chemistry</subject><subject>Dissolution assay</subject><subject>Dissolution kinetics</subject><subject>Drug Carriers</subject><subject>General pharmacology</subject><subject>Hardness</subject><subject>Hydrogen-Ion Concentration</subject><subject>Hypromellose</subject><subject>Hypromellose Derivatives</subject><subject>Kinetics</subject><subject>Medical sciences</subject><subject>Methylcellulose - analogs &amp; derivatives</subject><subject>Methylcellulose - chemistry</subject><subject>Models, Chemical</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Sodium diclofenac</subject><subject>Solubility</subject><subject>Tablets</subject><subject>Technology, Pharmaceutical - methods</subject><subject>Temperature</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFkE1v1TAQRS0Eoo_CTwBlg7pKGH_ETlYIlVKQKiFVZW3NsyfUT0n8sB1E_z2pXgTLrmZz7p2rw9hbDg0Hrj8cmnA43mOaGgHQN5w3IMQztuOdkbVURj9nO5Cmq1tu5Bl7lfMBALTg8iU7432veK_Ujt1-DjnHcSkhztURE05UKOVqiKnK0YdlqnxwYxxoRle7OBcMc5h_VvcPxxQnGseYqZqwpPCnKrgfqbxmLwYcM73Z7jn78eXq7vJrffP9-tvlp5vayV6VugdBgoZWc1QetNYGUQo_dEYDAmlQQsgWBmr30GnX806hVtRz77XRwslzdnHqXYf8WigXO4Xs1kU4U1yyNVJ2WhrRrWR7Il2KOSca7DGFCdOD5WAfbdqD3WzaR5uWc7vaXHPvtg_LfiL_P7XpW4H3G4DZ4TgknF3I_zghlGkFh5X7eOJo9fE7ULLZBZod-ZDIFetjeGLKX5L-lmc</recordid><startdate>20100215</startdate><enddate>20100215</enddate><creator>Mourão, Samanta C.</creator><creator>da Silva, Cristiane</creator><creator>Bresolin, Tania M.B.</creator><creator>Serra, Cristina H.R.</creator><creator>Porta, Valentina</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100215</creationdate><title>Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet</title><author>Mourão, Samanta C. ; da Silva, Cristiane ; Bresolin, Tania M.B. ; Serra, Cristina H.R. ; Porta, Valentina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c394t-902e2ef561a4d06667aa32df8760a0e60422350fe5b086c9184a64e91dd6762c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anti-Inflammatory Agents, Non-Steroidal - chemistry</topic><topic>Biological and medical sciences</topic><topic>Buffers</topic><topic>Chemistry, Pharmaceutical</topic><topic>Delayed-Action Preparations</topic><topic>Diclofenac - chemistry</topic><topic>Dissolution assay</topic><topic>Dissolution kinetics</topic><topic>Drug Carriers</topic><topic>General pharmacology</topic><topic>Hardness</topic><topic>Hydrogen-Ion Concentration</topic><topic>Hypromellose</topic><topic>Hypromellose Derivatives</topic><topic>Kinetics</topic><topic>Medical sciences</topic><topic>Methylcellulose - analogs &amp; derivatives</topic><topic>Methylcellulose - chemistry</topic><topic>Models, Chemical</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Sodium diclofenac</topic><topic>Solubility</topic><topic>Tablets</topic><topic>Technology, Pharmaceutical - methods</topic><topic>Temperature</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mourão, Samanta C.</creatorcontrib><creatorcontrib>da Silva, Cristiane</creatorcontrib><creatorcontrib>Bresolin, Tania M.B.</creatorcontrib><creatorcontrib>Serra, Cristina H.R.</creatorcontrib><creatorcontrib>Porta, Valentina</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mourão, Samanta C.</au><au>da Silva, Cristiane</au><au>Bresolin, Tania M.B.</au><au>Serra, Cristina H.R.</au><au>Porta, Valentina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2010-02-15</date><risdate>2010</risdate><volume>386</volume><issue>1</issue><spage>201</spage><epage>207</epage><pages>201-207</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>Sodium diclofenac (SD) release from dosage forms has been studied under different conditions. However, no dissolution method that is discriminatory enough to reflect slight changes in formulation or manufacturing process, and which could be effectively correlated with the biological properties of the dosage form, has been reported. This study sought to develop three different formulae of SD-containing matrix tablets and to determine the effect of agitation speed in its dissolution profiles. F1, F2 and F3 formulations were developed using hypromellose (10, 20 and 30%, respectively for F1, F2 and F3) and other conventional excipients. Dissolution tests were carried out in phosphate buffer pH 6.8 at 37 °C using apparatus II at 50, 75 or 100 rpm. Dissolution efficiency (DE), T 50 and T 90 were determined and plotted as functions of the variables agitation speed and hypromellose concentration. Regarding DE, F2 showed more sensitivity to variations in agitation speed than F1 and F3. Increasing hypromellose concentration reduced DE values, independent of agitation speed. Analysis of T 50 and T 90 suggests that F1 is less sensitive to variations in agitation speed than F2 and F3. Most discriminatory dissolution conditions were observed at 50 rpm. Results suggest that the comparison of dissolution performance of SD matrix tablets should take into account polymer concentration and agitation conditions.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>19941944</pmid><doi>10.1016/j.ijpharm.2009.11.022</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2010-02, Vol.386 (1), p.201-207
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_733863728
source ScienceDirect Journals
subjects Anti-Inflammatory Agents, Non-Steroidal - chemistry
Biological and medical sciences
Buffers
Chemistry, Pharmaceutical
Delayed-Action Preparations
Diclofenac - chemistry
Dissolution assay
Dissolution kinetics
Drug Carriers
General pharmacology
Hardness
Hydrogen-Ion Concentration
Hypromellose
Hypromellose Derivatives
Kinetics
Medical sciences
Methylcellulose - analogs & derivatives
Methylcellulose - chemistry
Models, Chemical
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Sodium diclofenac
Solubility
Tablets
Technology, Pharmaceutical - methods
Temperature
title Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T16%3A59%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dissolution%20parameters%20for%20sodium%20diclofenac-containing%20hypromellose%20matrix%20tablet&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Mour%C3%A3o,%20Samanta%20C.&rft.date=2010-02-15&rft.volume=386&rft.issue=1&rft.spage=201&rft.epage=207&rft.pages=201-207&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/j.ijpharm.2009.11.022&rft_dat=%3Cproquest_cross%3E733863728%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c394t-902e2ef561a4d06667aa32df8760a0e60422350fe5b086c9184a64e91dd6762c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733863728&rft_id=info:pmid/19941944&rfr_iscdi=true